Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor-infiltrating cd68-positive cell counts in patients with egfr-mutant non-small cell lung cancer

Takeshi Tsuda, Kensuke Suzuki, Minehiko Inomata*, Kana Hayashi, Isami Mizushima, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Yasuaki Masaki, Hirokazu Taniguchi, Kazuyuki Tobe

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor-infiltrating cd68-positive cell counts in patients with egfr-mutant non-small cell lung cancer'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology